Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 Vaccine

M Kohli, M Maschio, A Lee, A Igarashi
doi: https://doi.org/10.1101/2023.10.24.23297475

Article Information

doi 
https://doi.org/10.1101/2023.10.24.23297475
History 
  • October 25, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. M Kohli1,*,
  2. M Maschio1,
  3. A Lee1 and
  4. A Igarashi2,3
  1. 1Quadrant Health Economics Inc; 92 Cottonwood Crescent, Cambridge, Ontario, Canada
  2. 2Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo City, Tokyo, 113-0033, Japan
  3. 3Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa Ward, Yokohama, Kanagawa Prefecture, 236-0004, Japan
  1. ↵*Correspondence:
    Michele Kohli, Quadrant Health Economics Inc.; 92 Cottonwood Crescent, Cambridge, Ontario, Canada; michele.kohli{at}quadrantHE.com
Back to top
Posted October 25, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 Vaccine
M Kohli, M Maschio, A Lee, A Igarashi
medRxiv 2023.10.24.23297475; doi: https://doi.org/10.1101/2023.10.24.23297475
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area